Division of Pulmonary, Critical Care & Sleep Medicine, The Ohio State University College of Medicine, Columbus, Ohio.
Division of Cardiac Surgery, The Ohio State University College of Medicine, Columbus, Ohio.
Am J Transplant. 2020 Oct;20(10):2923-2927. doi: 10.1111/ajt.16097. Epub 2020 Jun 11.
COVID-19, the clinical syndrome caused by the novel coronavirus, SARS-CoV-2, continues to rapidly spread, leading to significant stressors on global healthcare infrastructure. The manifestations of COVID-19 in solid organ transplant recipients are only beginning to be understood with cases reported to date in transplant recipients on chronic immunosuppression. Herein, we report the first case of COVID-19 in a lung transplant recipient in the immediate posttransplant period, and we describe the epidemiologic challenges in identifying the source of infection in this unique situation.
新型冠状病毒（SARS-CoV-2）引起的临床综合征——COVID-19 仍在迅速传播，对全球医疗基础设施造成了巨大压力。目前已有报告称，慢性免疫抑制的实体器官移植受者中出现了 COVID-19 病例，但在这些受者中 COVID-19 的表现才刚刚开始被了解。在此，我们报告了首例肺移植受者在移植后即刻发生 COVID-19 的病例，并描述了在这种特殊情况下确定感染源所面临的流行病学挑战。
